Skip to main content
ImmuneCited

Research Figures

333 figures from peer-reviewed research

All Andrographis Arginine Astaxanthin Astragalus Conjugated Linoleic Acid Cordyceps Curcumin Elderberry Glutathione Iron N-Acetylcysteine Omega-3 Fatty Acids (EPA/DHA) Pelargonium sidoides Quercetin Resveratrol Vitamin D Zinc
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 19
Figure 19 Chart

Graphical representation of outcomes in a study of astaxanthin Inhibits Oxidative Stress, highlighting trends observed across experimental conditions.

Astaxanthin Inhibits Oxidative Stress-Induced Ku Protein Degradation and Apoptosis in Gastric Epithelial …

Figure 6. MLN4924 and MG132 inhibited glucose/glucose oxidase (G/GO)−induced cell death, DNA fragmentation, and apoptosis. The cells were incubated with 5 nM MLN4924 or 0.5 µM MG132 for 1 h, then stimulated with G/GO for 16 h. (A) Viable cell counts were
Figure 20 Chart

MLN4924 and MG132 inhibited glucose/glucose oxidase (G/GO)−induced cell death, DNA fragmentation, and apoptosis. The cells were incubated with 5 nM MLN4924 or 0.5 µM MG132 for 1 h, then stimulated with G/GO for 16 h.

Astaxanthin Inhibits Oxidative Stress-Induced Ku Protein Degradation and Apoptosis in Gastric Epithelial …

Graphical Abstract
Figure 2 Diagram

Graphical abstract summarizing how astaxanthin supplementation may improve assisted reproductive technology outcomes in patients with poor ovarian response, highlighting proposed mechanisms of action.

Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating …

Figure 1. Chemical structure and mechanisms of action of quercetin. Quercetin exerts many mechanisms of action, including anti-allergic, anti-viral, antioxidant, and anti-inflammatory activities. For more details, see the text and Table 1.
Figure 1 Diagram

Chemical structure of quercetin and illustration of its mechanisms of action, including anti-inflammatory, antioxidant, and immunomodulatory pathways relevant to allergic conditions.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Figure 2
Figure 2 Chart

Pharmacological or clinical data supporting quercetin's potential applications for allergic rhinitis, asthma, or related inflammatory conditions.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Figure 3
Figure 3 Chart

Comparative efficacy data for quercetin in different formulations, examining the impact of delivery systems on therapeutic outcomes.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Figure 3. Plasma concentration of quercetin and its lecithin-based formulation. This pharmacokinetics study compared two groups of healthy volunteers supplemented with quercetin or quercetin phospholipids. Details are reported in the text. Partly modified
Figure 4 Chart

Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Keywords Astaxanthin, Infertility, Fertility, Reproduction, Oxidative stress, Assisted reproductive technology
Figure 2

Keywords Astaxanthin, Infertility, Fertility, Reproduction, Oxidative stress, Assisted reproductive technology

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 3
Figure 3

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 4
Figure 4

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 5
Figure 5

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 6
Figure 6

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 7
Figure 7

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

Figure 8
Figure 8

Effect of astaxanthin supplementation on female fertility and reproductive outcomes: a systematic …

FIGURE 1. Peripheral blood mononuclear cells are stimulated by resveratrol to release anti-inflammatory cytokines, which subsequently prevent chronic inflammation and the growth of cancer cells. M-monocytes and macrophages, L-large lymphocytes, SL-small lym
Figure 1

FIGURE 1. Peripheral blood mononuclear cells are stimulated by resveratrol to release anti-inflammatory cytokines, which subsequently prevent chronic inflammation and the growth of cancer cells. M-monocytes and macrophages, L-large lymphocytes, …

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

FIGURE 2. A schematic presentation of some of the mechanisms by which resveratrol may induce cancer cells’ death. The knowledge about the impact of RSV on cuproptosis is limited, as shown by the question mark. Ca cell-cancer cell.
Figure 2

FIGURE 2. A schematic presentation of some of the mechanisms by which resveratrol may induce cancer cells’ death. The knowledge about the impact of RSV on cuproptosis is limited, as …

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

Figure 1
Figure 1

Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and reactive oxygen species
Figure 1

Figure 1. Role of lysosomal dysfunction in the progression of cardiovascular disease (CVD). Lysosomal dysfunction, characterized by lysosomal membrane permeabilization and lipid accumulation, leads to the release of cathepsins and …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosom
Figure 2

Figure 2. Therapeutic strategies targeting lysosomal dysfunction in cardiovascular diseases. This schematic illustrates lysosomal dysfunction as a central contributor to CVDs and highlights emerging therapeutic strategies targeting these pathways. Lysosomal …

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 3
Figure 3

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 4
Figure 4

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future …

Figure 1 Levels of total protein in TNF-a induced secretion in human adipocytes. Results are shown as the means ± SEM of triplicate determinations. Statistic Dunnett’s multiple comparison test VS Ctrl - TNF-a signification is represented by * P values les
Figure 1

Figure 1 Levels of total protein in TNF-a induced secretion in human adipocytes. Results are shown as the means ± SEM of triplicate determinations. Statistic Dunnett’s multiple comparison test VS …

In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic …

Figure 2
Figure 2

In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic …

Figure 3
Figure 3

In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic …

Page 12 of 14